Alireza Faridar

Methodist Hospital Research Institute

$1,227,361

Attributed

$2,708,125

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.4M · FY2023–25

$2M$1.5M$1M$500K$0

'23

'24

'25

Funding mix

By agency

NIH$2,708,125 · 2

By mechanism

R01$1,947,918 · 1

R56$760,207 · 1

Top collaborators

Most similar at Methodist Hospital Research Institute

Same institution · by research overlap

Belen Pascual$973,959
Qing Yi$20,966,577
Kyuson Yun$4,256,934

Others in their field

Other Rising Stars on “Alzheimer&Apos”

Kjetil Bjornevik · Harvard University D/B/A Harvard School Of Public Health$3,280,861
Yanling Wang · Rush University Medical Center$2,986,919
William G Mantyh · University Of Minnesota$2,961,521
Allison Mercedes Caban-Holt · University Of Miami School Of Medicine$2,611,182
Brian Stephen Appleby · Cleveland Clinic Lerner Com-Cwru$2,482,260
Noah Ray Johnson · University Of Colorado Denver$2,282,487

Research focus

Alzheimer&AposSample SizeImmuneNeurogliaProteomicsRestorationInflammationImmune SystemInflammatoryMicrogliaAmyloidBrainPublic Health RelevanceRegulatory T-LymphocytePeripheralChemokineAstrocytesChronicCellsDisease ProgressionBiological MarkersCytokineBloodS Disease

Grant awards (4)

Central and peripheral immune cross-talk in Alzheimer's disease and their modulation by a novel immunotherapy$644,840

R01 · FY2025 · AG · contact PI

Multi-omic integrative analysis of shared and distinct inflammation networks across neurodegenerative disorders$760,207

R56 · FY2024 · AG · contact PI

Central and peripheral immune cross-talk in Alzheimer's disease and their modulation by a novel immunotherapy$651,539

R01 · FY2024 · AG · contact PI

Central and peripheral immune cross-talk in Alzheimer's disease and their modulation by a novel immunotherapy$651,539

R01 · FY2023 · AG · contact PI